152 related articles for article (PubMed ID: 26108417)
1. Pharmacological stress cardiovascular magnetic resonance: feasibility and safety in a large multicentre prospective registry.
Monmeneu Menadas JV; Lopez-Lereu MP; Estornell Erill J; Garcia Gonzalez P; Igual Muñoz B; Maceira Gonzalez A
Eur Heart J Cardiovasc Imaging; 2016 Mar; 17(3):308-15. PubMed ID: 26108417
[TBL] [Abstract][Full Text] [Related]
2. Vasodilatation stress cardiovascular magnetic resonance imaging: Feasibility, workflow and safety in a large prospective registry of more than 35,000 patients.
Pezel T; Garot P; Hovasse T; Unterseeh T; Champagne S; Kinnel M; Toupin S; Louvard Y; Morice MC; Sanguineti F; Garot J
Arch Cardiovasc Dis; 2021; 114(6-7):490-503. PubMed ID: 34274252
[TBL] [Abstract][Full Text] [Related]
3. Quantification of myocardial blood volume during dipyridamole and doubtamine stress: a perfusion CMR study.
McCommis KS; Goldstein TA; Zhang H; Misselwitz B; Gropler RJ; Zheng J
J Cardiovasc Magn Reson; 2007; 9(5):785-92. PubMed ID: 17891616
[TBL] [Abstract][Full Text] [Related]
4. [Complications of stress echocardiography].
Hirano Y; Yamamoto T; Uehara H; Nakamura H; Wufuer M; Yamada S; Ikawa H; Ishikawa K
J Cardiol; 2001 Aug; 38(2):73-80. PubMed ID: 11525112
[TBL] [Abstract][Full Text] [Related]
5. Safety and tolerability of regadenoson in comparison with adenosine stress cardiovascular magnetic resonance: Data from a multicentre prospective registry.
Monmeneu Menadas JV; García Gonzalez MP; Lopez-Lereu MP; Higueras Ortega L; Maceira Gonzalez AM
Int J Cardiovasc Imaging; 2022 Jan; 38(1):195-209. PubMed ID: 34331614
[TBL] [Abstract][Full Text] [Related]
6. Safety and feasibility of high-dose dobutamine-atropine stress cardiovascular magnetic resonance for diagnosis of myocardial ischaemia: experience in 1000 consecutive cases.
Wahl A; Paetsch I; Gollesch A; Roethemeyer S; Foell D; Gebker R; Langreck H; Klein C; Fleck E; Nagel E
Eur Heart J; 2004 Jul; 25(14):1230-6. PubMed ID: 15246641
[TBL] [Abstract][Full Text] [Related]
7. Dobutamine stress MRI. Part I. Safety and feasibility of dobutamine cardiovascular magnetic resonance in patients suspected of myocardial ischemia.
Kuijpers D; Janssen CH; van Dijkman PR; Oudkerk M
Eur Radiol; 2004 Oct; 14(10):1823-8. PubMed ID: 15278415
[TBL] [Abstract][Full Text] [Related]
8. [Complications of stress-echocardiography used for diagnosis of ischemic heart disease].
Mikheev NN
Kardiologiia; 2008; 48(1):19-23. PubMed ID: 18260991
[TBL] [Abstract][Full Text] [Related]
9. The atropine factor in pharmacologic stress echocardiography. Echo Persantine (EPIC) and Echo Dobutamine International Cooperative (EDIC) Study Groups.
Pingitore A; Picano E; Colosso MQ; Reisenhofer B; Gigli G; Lucarini AR; Petix N; Previtali M; Bigi R; Chiarandà G; Minardi G; de Alcantara M; Lowenstein J; Sclavo MG; Palmieri C; Galati A; Seveso G; Heyman J; Mathias W; Casazza F; Sicari R; Raciti M; Landi P; Marzilli M
J Am Coll Cardiol; 1996 Apr; 27(5):1164-70. PubMed ID: 8609337
[TBL] [Abstract][Full Text] [Related]
10. [Prevalence of dangerous arrhythmia during pharmacological stress echocardiography].
Wejner-Mik P; Drozdz J; Lipiec P; Krzemińska-Pakuła M; Ciesielczyk M; Kasprzak JD
Pol Merkur Lekarski; 2006 Jun; 20(120):635-8. PubMed ID: 17007256
[TBL] [Abstract][Full Text] [Related]
11. MR of the heart under pharmacologic stress.
de Roos A; Niezen RA; Lamb HJ; Dendale P; Reiber JH; van der Wall EE
Cardiol Clin; 1998 May; 16(2):247-65. PubMed ID: 9627759
[TBL] [Abstract][Full Text] [Related]
12. [Study of efficacy and safety of pharmacological stress tests in nuclear cardiology].
Baskot B; Rafajlovski S; Ristić-Angelkov A; Obradović S; Gligić B; Orozović V; Agbaba N
Vojnosanit Pregl; 2009 Mar; 66(3):193-8. PubMed ID: 19341223
[TBL] [Abstract][Full Text] [Related]
13. Severe hypotension induced by combination of dobutamine and dipyridamole.
Shaheen J; Rosenmann D; Tzivoni D
Isr J Med Sci; 1996 Nov; 32(11):1105-7. PubMed ID: 8960082
[TBL] [Abstract][Full Text] [Related]
14. Complications of pharmacologic stress echocardiography in coronary artery disease.
Bigi R
Clin Cardiol; 1996 Oct; 19(10):776-80. PubMed ID: 8896909
[TBL] [Abstract][Full Text] [Related]
15. Pharmacologic stress testing: understanding the options.
White MP
J Nucl Cardiol; 1999; 6(6):672-5. PubMed ID: 10608596
[No Abstract] [Full Text] [Related]
16. [Myocardial perfusion scintigraphy with Tc-99m MIBI in patients with left bundle branch block: Visual quantification of the anteroseptal perfusion imaging for the diagnosis of left anterior descending artery stenosis].
Möller J; Warwick J; Bouma H
Cardiovasc J S Afr; 2005; 16(2):95-101. PubMed ID: 15915276
[TBL] [Abstract][Full Text] [Related]
17. Safety and feasibility of dobutamine and dipyridamole stress echocardiography in hypertensive patients.
Cortigiani L; Zanetti L; Bigi R; Desideri A; Fiorentini C; Nannini E
J Hypertens; 2002 Jul; 20(7):1423-9. PubMed ID: 12131540
[TBL] [Abstract][Full Text] [Related]
18. Stress cardiovascular MR in routine clinical practice: referral patterns, accuracy, tolerance, safety and incidental findings.
Khoo JP; Grundy BJ; Steadman CD; Sonnex EP; Coulden RA; McCann GP
Br J Radiol; 2012 Oct; 85(1018):e851-7. PubMed ID: 22457320
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of pharmacologic stress echocardiography in patients with idiopathic dilated cardiomyopathy: a prospective, head-to-head comparison between dipyridamole and dobutamine test.
Pratali L; Otasevic P; Neskovic A; Molinaro S; Picano E
J Card Fail; 2007 Dec; 13(10):836-42. PubMed ID: 18068617
[TBL] [Abstract][Full Text] [Related]
20. Ultra-early risk stratification after myocardial infarction via pharmacological stress echocardiography: the relative value of resting function, viability and myocardial ischemia.
Sclavo M; Aruta E; Presbitero P
G Ital Cardiol; 1997 Oct; 27(10):1000-7. PubMed ID: 9359049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
